AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Fluor Corporation
Video analysis: FLR
All videosNo video analysis for this stock yet. Request one from our team.
News: FLR
Hsbc Holdings PLC Acquires 22,500 Shares of Fluor Corporation $FLR
Hsbc Holdings PLC raised its position in Fluor Corporation (NYSE: FLR) by 57.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,671 shares of the construction company's stock after purchasing an additional 22,500 shares during the quarter. Hsbc Holdings PLC's holdings
(PODCAST) Voyageur Pharmaceuticals (TSXV:VM) Achieves First Milestone in Bayer Collaboration, Secures USD $1 Million Payment
CALGARY, Alberta — September 10 , 2026 — Leads & Copy — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF), a Canadian company focused on developing pharmaceutical-grade barium and iodine contrast media for medical imaging, has achieved its first milestone under a non-dilutive Collaboration and Funding Agreement with Bayer AG. The company announced that it successfully submitted a complete feasibility work plan and timetable, which has been approved by Bayer. The milestone achievement triggers the first major non-dilutive payment of USD $1,000,000 from Bayer. This payment, combined with the initial USD $350,000 received on March 31, 2026, brings the total funding received by Voyageur from Bayer to USD $1,350,000 of the committed USD $2,350,000.
Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment
CALGARY, Alberta – TheNewswire - September 9, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“ Voyageur ” or the “ Company ”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has achieved the first milestone under its non-dilutive Collaboration and Funding Agreement with Bayer AG (“ Bayer ”) dated February 10, 2026 (the “ Agreement ”) by submitting a complete feasibility work plan and timetable which has been approved by Bayer. (Collaboration funding news https://finance.yahoo.com/news/voyageur-pharmaceuticals-announces-collaboration-bayer-144926270.html )
Construction Firms Powering the Nuclear Renaissance
Investors usually focus on reactor developers and uranium miners when deciding on allocations for investing in the nuclear renaissance. A narrow view on the nuclear sector could result in missed opportunities for investment returns in nuclear-adjacent companies.
Is Fluor (FLR) Stock Outpacing Its Construction Peers This Year?
Here is how Fluor (FLR) and James Hardie (JHX) have performed compared to their sector so far this year.
Nuclear Energy Scaling Up Through New Federal Projects
Two of the most significant government-led nuclear energy programs are illustrating how quickly the advanced nuclear field is expanding. The Nuclear Energy Launch Pad added 13 reactor and fuel cycle technology projects to its development pipeline.
Algert Global LLC Has $7.57 Million Stock Holdings in Fluor Corporation $FLR
Algert Global LLC lifted its position in Fluor Corporation (NYSE: FLR) by 14.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 144,400 shares of the construction company's stock after buying an additional 18,190 shares during the period.
Fluor Corp.: The Turnaround Is Gaining Traction, But Execution Remains The Test
Fluor Corporation is executing a multi-year turnaround, shifting to reimbursable contracts and leveraging AI to improve project execution and margins. FLR's $27B backlog is nearly 4x its $7.3B market cap, with 85% now reimbursable, reducing legacy fixed-price risk and enhancing earnings visibility. Management's modernization, AI-driven project controls, and focus on high-demand sectors—nuclear, data centers, and defense—increase FLR's strategic positioning.
